You mean corpos and governments will own everything and issue us food stamps so we can buy some bug meals and biomade slop and do what? Oil paintings and gardening all day? I dunno

Strategic infrastructure isn't just roads and power grids anymore. It's tokenized stock exchanges, bioindustrial manufacturing, industrial cybersecurity, and defense production lines. @NYSE just announced a 24/7 tokenized trading platform with on chain settlement. BioMADE funded 14 projects spanning biomining to AI enabled protein production. The new issue of Global Signals breaks down what these shifts mean for science diplomacy, investment, and competitiveness. Read and subscribe: global-signals.ghost.io

Packaging sostenibile per industria e food: film, cling film, shopper, Biomade® e progetti customizzati. Scopri le soluzioni Polycart 🔗polycart.eu/produzione/ #Polycart #IOPENSOBIO #PackagingSostenibile #Biomade

Burns & McDonnell to lead EPC services for new BioMADE pilot facility in Minnesota indianchemicalnews.com/techn… #BurnsMcDonnell #EPC #BioMADE #contractdevelopmentandmanufacturingorganization @BurnsMcDonnell @TheBioMADE

The 2026 BioMADE Member Meeting is gearing up for two days of powerful sessions designed to spark innovation, tackle big challenges, and accelerate U.S. biomanufacturing capabilities. Register now and let's build the future of biomanufacturing together: biomademeeting.org

Tämmönen > löyty aiheeseen liittyen Kesällä 2024 Yhdysvaltain puolustusministeriö (DoD/Pentagon) rahoitti BioMADE-nimistä julkisen ja yksityisen sektorin konsortiota, joka sai yli 500 miljoonaa dollaria veronmaksajien rahoja. BioMADE julkaisi haun ehdotuksille, joissa kehitettäisiin mm. laboratoriossa viljeltyä lihaa/proteiinia sotilaille tarkoitettuihin ravinteikkaisiin annoksiin. Tavoitteena oli vähentää CO₂-päästöjä ilmastotavoitteiden mukaisesti ja kehittää kestäviä vaihtoehtoja perinteiselle lihalle. NCBA (National Cattlemen’s Beef Association) ja muut karjatalousjärjestöt hyökkäsivät voimakkaasti suunnitelmaa vastaan> he kutsuivat sitä "sotilaiden ruokkimiseksi koe-eläiminä" (guinea pigs), "kemikaalitäytteiseksi ultra-prosessoiduksi tuotteeksi" ja "nöyryyttäväksi" amerikkalaisille sotilaille. Kongressissa (mm. republikaaniedustajat kuten Don Bacon) tehtiin muutosehdotuksia rahoituksen estämiseksi. Heinäkuussa 2024 DoD perääntyi: he vahvistivat, ettei laboratoriolihaa kehitetä eikä oteta käyttöön sotilaiden ruokavalioon ihmiskulutukseen (human consumption). Rahoitus keskitettiin muualle, eikä projektia jatkettu tällä tavalla. Lähteet vahvistavat tämän (esim. NCBA:n tiedote 23.7.2024, Cowboy State Daily, AGDAILY, Green Queen ym.).

At @numaferm , we are pioneering the future of biomade peptides. We use proprietary switchtag technologies to scale valuable peptide production in E.coli. To support our rapid growth, we are currently expanding our team in Düsseldorf with two key full-time positions.(1/3)👇

Iowa continues to pave the way for biomanufacturing! The latest example? ➡️ BioMADE, the State of Iowa, Iowa State University and the Iowa State University Research Park celebrated the groundbreaking of a new pilot-scale bioindustrial manufacturing facility near Ames last week.

Representatives of Iowa State, the state of Iowa and BioMADE recently celebrated the launch of a $40 million biomanufacturing pilot plant based at the university's BioCentury Research Farm. The plant is expected to open in 2027. 📰biomade.org/news/iowa-facili…

Gov. Kim Reynolds breaks ground on $40 million BioMADE biomanufacturing facility in Boone desmoinesregister.com/story/…

It’s an exciting day as BioMADE breaks ground on a new pilot-scale bioindustrial manufacturing facility at ISU’s BioCentury Research Farm.   Today is about implementing a vision to create a strong, resilient, and secure US bio manufacturing base—one that will drive innovation, strengthen American competitiveness and supply-chain resiliency, and position Iowa to lead the bio-economy.

Ames is becoming a biotech powerhouse. A new $40M BioMADE facility at @IowaStateU will help startups scale bioindustrial manufacturing, backed by the @DeptofDefense & @IowaEDA. Opening 2028 → built to keep innovation — and jobs — in the U.S. businessrecord.com/bringing-…

Hidden in the FY2026 U.S. Defense Budget, Congress approved $640M for “biological technologies for defense resilience” with a 40% jump in two years. Days later, the DoD-funded BioMADE Institute met behind closed doors in Washington with DARPA’s Biological Technologies Office to discuss “defense applications of biomanufacturing resilience.” What’s happening? The Pentagon is quietly building a synthetic biology supply chain — turning living cells into factories that can make fuels, materials, or medicines on demand. For the military, it means self-producing logistics: a drone that grows its own parts, or a bioreactor that prints vaccines in the field. For civilians, it’s about control — public money and university labs being folded into defense production, while oversight and ethics trail far behind. Biology is becoming infrastructure. Life itself is being engineered as a strategic asset. That’s why it matters — and why you haven’t heard about it until now. Sources: FY2026 NDAA; White House OSTP, Oct 2025; BioMADE Meeting Agenda; NIST Manufacturing USA Plan 2024.

The future of fashion could be brewed and biodesigned. Kenji Higashi, EVP of Spiber Inc., will speak on “Scaling Biomade Materials” at the BioInnovation Summit and share how Brewed Protein™ fibers are advancing the biomaterials industry. jamboree.igem.org/2025/progr…

The @b2idigital team is pleased to introduce @eXoZymes (Nasdaq: EXOZ) as a new B2i Digital Featured Company. A full company profile will be available soon at b2idigital.com/featured-comp… eXoZymes is a Los Angeles, California-based biotechnology company pioneering cell-free biomanufacturing through its proprietary exozyme platform. The company has developed AI-engineered enzymes that operate outside living cells to transform sustainable feedstock into nutraceuticals, medicines, and essential chemicals, offering a scalable and commercially viable alternative to traditional petrochemical production methods, natural extraction, or synthetic biology. Founded on technology validated through multiple peer-reviewed publications in Nature Communications and Nature Chemical Biology, eXoZymes focuses on high-value, low-volume products including active pharmaceutical ingredients, nutraceuticals, and sustainable aviation fuel. The company recently demonstrated its platform’s capabilities by achieving gram-scale production of NCT (a nutraceutical compound) with over 99% purity in just five months, showcasing the speed and efficiency of its cell-free approach. With $1.4 million in grant income through Q2 2025 from sources including NIH, NSF, and BioMADE, eXoZymes is advancing multiple projects including its lead NCT program targeting the non-alcoholic fatty liver disease (NAFLD) treatment market, estimated at $21 billion. The company’s BioClick platform, supported by NIH, accelerates enzyme engineering through high-throughput screening capabilities and novel ways of implementing AI. eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, VP of Research and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Dr. Zachary Karl, Ph.D., VP of Business Development; and Lasse H. Görlitz, VP of Communications & IR. To learn more about eXoZymes Inc., visit exozymes.com. For investor inquiries, visit exozymes.com/investor Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at b2idigital.com

@eXoZymes $EXOZ is establishing itself as cell-free biomanufacturing's thought leader: - Leadership/Technical committee appointment to BioMade - eXoZymes selected as core industry partner for $9m grant to advance cell-free biomanufacturing - eXoZymes is crafting the language, terminology and standards as first movers (GEN Tech) - Yannick Bombel, NREL, reached out to Tyler Korman after releasing the significance of the tech - Seemingly the only global Exozyme system company - Holds all the core patents and has numerous trade secrets

Driving the cell-free revolution: @eXoZymes leaders join @TheBioMADE Leadership & Technical Committees. This underscores eXoZymes’ commitment to - and growing influence as a thought leader in - cell-free biomanufacturing. Chief Commercial Officer at eXoZymes, Damien Perriman (@Perriman), states, "Being elected to the BioMADE Leadership Council is both an honor and a responsibility. This is a pivotal moment where cell-free biomanufacturing is stepping into the national spotlight. At eXoZymes, we believe our technology will be instrumental in driving the shift toward faster, more scalable, and more resilient biomanufacturing. I look forward to working with fellow council members to shape priorities that unlock real-world impact across industries - from fuels to functional ingredients.” Co-founder and VP of Development, Dr. Paul Opgenorth (@popgenorth), states, “The Technical Committee is where the details of innovation become the standards that move an industry forward. I’m excited to play a role in defining a technical roadmap for developing and deploying cell-free enzyme pathways in the real world that can accelerate biosolution development cycles, remove the cell-based bottlenecks, and make a new generation of highly valuable natural product molecules commercially viable at scale.” Full story here: hubs.la/Q03LB2sg0 #enzyme #syntheticbiology #biomanufacturing #biosolution #exozyme #cellfree #exozymes #enzymes #synbio

The global bioeconomy could reach $30T USD by 2030, but how do we turn its possibilities into impact? Join Dr. Genya Dana (BioMADE) for our 3rd BioVisionaries webinar on scaling biotechnology through strategy, policy and partnerships. Register: igem-org.zoom.us/j/878883711…

Big news for Iowa's bioscience future! Governor Reynolds announces that BioMADE has chosen Iowa for a cutting-edge bioindustrial manufacturing facility at ISU’s BioCentury Research Farm, boosting innovation, jobs, and the ag-based economy. Read more here: news.iastate.edu/news/isu-in…

BioMADE is pleased to announce its plans to establish and operate a new pilot-scale bioindustrial manufacturing facility near Ames, Iowa: biomade.org/news/facility-in…